Intratumoral dendritic cell immunotherapy
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Intratumoral dendritic cell immunotherapy, covering 2012-11-08 to 2012-11-08. Get the full timeline:
Most recent: Clinical Trial Update: Phase I/II Intratumoral DC Immunotherapy With Gemcitabine & XRT in Unresectable Pancreatic Cancer [Phase 1]